Sleep latency on the maintenance of wakefulness test (MWT) for 530 patients with narcolepsy while free of psychoactive drugs
- PMID: 9743270
- DOI: 10.1016/s0013-4694(98)00044-3
Sleep latency on the maintenance of wakefulness test (MWT) for 530 patients with narcolepsy while free of psychoactive drugs
Abstract
Objectives: To compare maintenance of wakefulness test (MWT) data gathered at baseline in the course of two, multicenter studies on the therapeutic efficacy of modafinil with published MWT norms.
Methods: The MWT is a procedure that uses electrophysiological measures to determine the ability to remain awake while sitting in a quiet, darkened room. The test consists of 4 20 min trials conducted 4 times at 2 h intervals commencing 2 h after awakening from a night of sleep. MWT data were gathered at baseline in the course of two, multicenter studies on the therapeutic efficacy of modafinil. Subjects were 17-68 year old men (n = 239) and women (n = 291) diagnosed with narcolepsy according to the International Classification of Sleep Disorders (ICSD). All patients were free of psychoactive medication for a minimum of 14 days.
Results: Mean MWT sleep latency was 6.0 +/- 4.8 min. However, the mean for the first MWT trial was 7.0 min which was longer that the means for the following 3 trials (5.8, 5.6 and 5.7 min, respectively). The 4 distributions of the individual MWT trials were similar and adequately summarized by the distribution of the average MWT sleep latency. As a group, patients with narcolepsy were less able to remain awake than normals; only 8 of 530 (1.5%) patients were able to remain awake on 4 20 min MWT trials compared with 35 of 64 (54.7%) normals in another study. However, using a mean MWT sleep latency of 12 min (the 5th percentile for normals) as the lowest cut-point for normalcy, 15% of patients with narcolepsy appeared to have an unimpaired ability to remain awake.
Conclusions: The diagnosis of narcolepsy did not always predict inability to remain awake on the MWT. Age, gender and the duration of illness did not predict ability to remain awake. Patients with severe cataplexy and other ancillary symptoms were least able to remain awake on MWT trials. Patients who used tobacco and caffeine moderately had the lowest MWT sleep latencies relative to patients with heavy and light use.
Similar articles
-
Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy.Sleep Med. 2016 Aug;24:57-62. doi: 10.1016/j.sleep.2016.07.010. Epub 2016 Aug 22. Sleep Med. 2016. PMID: 27810187 Clinical Trial.
-
Visual P300 latency predicts treatment response to modafinil in patients with narcolepsy.Clin Neurophysiol. 1999 Jun;110(6):1041-7. doi: 10.1016/s1388-2457(99)00035-8. Clin Neurophysiol. 1999. PMID: 10402091 Clinical Trial.
-
Effects of modafinil on wakefulness and executive function in patients with narcolepsy experiencing late-day sleepiness.Clin Neuropharmacol. 2004 Mar-Apr;27(2):74-9. doi: 10.1097/00002826-200403000-00005. Clin Neuropharmacol. 2004. PMID: 15252267 Clinical Trial.
-
Objective measures of sleepiness and wakefulness: application to the real world?J Clin Neurophysiol. 2006 Feb;23(1):39-49. doi: 10.1097/01.wnp.0000190416.62482.42. J Clin Neurophysiol. 2006. PMID: 16514350 Review.
-
[Multiple sleep latency test, maintenance of wakefulness test and suggestive immobilization test].Nihon Rinsho. 2015 Jun;73(6):971-9. Nihon Rinsho. 2015. PMID: 26065128 Review. Japanese.
Cited by
-
Effects of Chronic Administration of Green Tea Ethanol Extract on Sleep Architecture in Mice: A Comparative Study with a Representative Stimulant Caffeine.Nutrients. 2023 Feb 20;15(4):1042. doi: 10.3390/nu15041042. Nutrients. 2023. PMID: 36839400 Free PMC article.
-
Manipulation of core body and skin temperature improves vigilance and maintenance of wakefulness in narcolepsy.Sleep. 2008 Feb;31(2):233-40. doi: 10.1093/sleep/31.2.233. Sleep. 2008. PMID: 18274271 Free PMC article.
-
Narcolepsy in the older adult: epidemiology, diagnosis and management.Drugs Aging. 2003;20(5):361-76. doi: 10.2165/00002512-200320050-00005. Drugs Aging. 2003. PMID: 12696996 Review.
-
Clinical and neurobiological aspects of narcolepsy.Sleep Med. 2007 Jun;8(4):373-99. doi: 10.1016/j.sleep.2007.03.008. Epub 2007 Apr 30. Sleep Med. 2007. PMID: 17470414 Free PMC article. Review.
-
EEG-mapping differences between narcolepsy patients and controls and subsequent double-blind, placebo-controlled studies with modafinil.Eur Arch Psychiatry Clin Neurosci. 2005 Feb;255(1):20-32. doi: 10.1007/s00406-004-0530-1. Epub 2004 Nov 12. Eur Arch Psychiatry Clin Neurosci. 2005. PMID: 15538594 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials